共 50 条
- [4] Treatment patterns among patients with relapsed/refractory multiple myeloma (RRMM) in Taiwan [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S188 - S189
- [6] Treatment Patterns Among Patients With Relapsed/Refractory Multiple Myeloma (RRMM) Receiving Secondand Third-Line Therapy in a Medicare Population [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S423 - S423
- [9] Comparison of daratumumab-based regimens as second-line therapy in relapsed/refractory multiple myeloma [J]. Blood Cancer Journal, 13